CUROVIR AB has a total of 20 patent applications. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SPLICOS SOC, FARMAK INTERNAT HOLDING GMBH and ARTAX BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | United States | 3 | |
#5 | Brazil | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | China | 1 | |
#8 | Russian Federation | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Westman Jacob | 17 |
#2 | Jacob Westman | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021032611A1 | Heteroaromatic compounds useful in therapy | |
WO2020074160A1 | Condensed pyrimidine or pyridazine derivatives as antiviral agents | |
CA3115128A1 | 2,6-dimethyl-n-((pyridin-4-yl)methyl)imidazo[1,2-b]pyridazin-8-amine and 2,5-dimethyl-n-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivatives for treating viral infections | |
CN110520424A | Heteroaromatics for therapy | |
EP3313842A1 | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy | |
US2016318937A1 | Pyrazolo[1,5-a]pyrimidines as antiviral compounds |